Jubilant Pharmova Ltd (JUBLPHARMA) — Announcement | 29 September 2026
Jubilant Pharmova announced that its trading window closes on October 1, 2026, ahead of Q2 results, restricting insider trading until 48 hours after financial results are declared.
About Jubilant Pharmova Ltd (JUBLPHARMA)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when JUBLPHARMA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track JUBLPHARMA — Free💡 Ask AI about this filing
📊 More JUBLPHARMA filings
- 🔴 Corporate Action — 28 September 2026Jubilant Pharmova sent a specimen letter to shareholders on September 28, 2026, informing them that ...
- 🔴 Announcement — 11 September 2026Jubilant Pharmova disclosed that its US subsidiary Jubilant HollisterStier LLC received a 'Voluntary...
- 🔴 Announcement — 1 September 2026Jubilant Pharmova received a GST show cause notice from Mysore tax authorities on August 31, 2026, d...
- 🔴 Announcement — 28 August 2026Jubilant Pharmova disclosed receipt of a GST show cause notice from the Joint Commissioner of CGST, ...
- 🟡 Board Meeting — 26 August 2026Jubilant Pharmova held its 48th AGM on August 26, 2026, via video conference, passing all resolution...
🔥 Also filed on 29 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when JUBLPHARMA files new disclosures
Track JUBLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track JUBLPHARMA — FreeFree account · 2 AI queries/day